0001209191-14-012773.txt : 20140221 0001209191-14-012773.hdr.sgml : 20140221 20140221070341 ACCESSION NUMBER: 0001209191-14-012773 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140220 FILED AS OF DATE: 20140221 DATE AS OF CHANGE: 20140221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 801 CORPORATE CENTER DRIVE STREET 2: SUITE 210 CITY: RALEIGH STATE: NC ZIP: 27607 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 801 CORPORATE CENTER DRIVE STREET 2: SUITE 210 CITY: RALEIGH STATE: NC ZIP: 27607 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Finn Andrew L CENTRAL INDEX KEY: 0001302103 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 14631639 MAIL ADDRESS: STREET 1: C/O BIODELIVERY SCIENCES INTL, INC. STREET 2: 801 CORPORATE CENTER DRIVE, SUITE 210 CITY: RALEIGH STATE: NC ZIP: 27607 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-02-20 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001302103 Finn Andrew L C/O BIODELIVERY SCIENCES INTL, INC. 801 CORPORATE CENTER DRIVE, SUITE 210 RALEIGH NC 27607 0 1 0 0 Executive Vice President Common Stock 2014-02-20 4 A 0 53534 8.90 A 759187 D Common Stock 2014-02-20 4 S 0 18737 8.84 D 740450 D The shares of common stock reported on this Form 4 were acquired by the Reporting Person as a result of the vesting of one-third units under a previous Restricted Stock Unit grant. The sale of the shares of common stock was made pursuant to a pre-planned 10b5-1 plan. On February 20, 2014, the Reporting Person sold an aggregate of 18,737 shares of the Issuer's Common Stock at a weighted average price of $8.84. The highest sale price for the Common Stock was $8.91 per share and the lowest sale price was $8.75 per share. /s/ Andrew L. Finn 2014-02-21